rs565977953

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_016027.3(LACTB2):​c.256A>G​(p.Ile86Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,460,452 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I86T) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.000013 ( 0 hom. )

Consequence

LACTB2
NM_016027.3 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.14

Publications

0 publications found
Variant links:
Genes affected
LACTB2 (HGNC:18512): (lactamase beta 2) Enables endoribonuclease activity; single-stranded RNA binding activity; and zinc ion binding activity. Involved in RNA phosphodiester bond hydrolysis, endonucleolytic. Located in mitochondrial matrix. [provided by Alliance of Genome Resources, Apr 2022]
LACTB2-AS1 (HGNC:27841): (LACTB2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.15689424).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LACTB2NM_016027.3 linkc.256A>G p.Ile86Val missense_variant Exon 2 of 7 ENST00000276590.5 NP_057111.1 Q53H82A0A024R811
LACTB2-AS1NR_038881.1 linkn.2201T>C non_coding_transcript_exon_variant Exon 4 of 4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LACTB2ENST00000276590.5 linkc.256A>G p.Ile86Val missense_variant Exon 2 of 7 1 NM_016027.3 ENSP00000276590.4 Q53H82
LACTB2-AS1ENST00000499227.6 linkn.2201T>C non_coding_transcript_exon_variant Exon 4 of 4 1
LACTB2ENST00000522447.5 linkc.256A>G p.Ile86Val missense_variant Exon 2 of 8 2 ENSP00000428801.1 Q53H82

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.0000400
AC:
10
AN:
249984
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.0000130
AC:
19
AN:
1460452
Hom.:
0
Cov.:
30
AF XY:
0.0000124
AC XY:
9
AN XY:
726472
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33416
American (AMR)
AF:
0.00
AC:
0
AN:
44332
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26102
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39654
South Asian (SAS)
AF:
0.000151
AC:
13
AN:
85836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53324
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
9.00e-7
AC:
1
AN:
1111688
Other (OTH)
AF:
0.0000829
AC:
5
AN:
60336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
ExAC
AF:
0.0000247
AC:
3
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 25, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.256A>G (p.I86V) alteration is located in exon 2 (coding exon 2) of the LACTB2 gene. This alteration results from a A to G substitution at nucleotide position 256, causing the isoleucine (I) at amino acid position 86 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
18
DANN
Benign
0.87
DEOGEN2
Benign
0.19
T;T
Eigen
Benign
-0.34
Eigen_PC
Benign
-0.083
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Uncertain
0.87
.;D
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.16
T;T
MetaSVM
Benign
-0.76
T
MutationAssessor
Benign
-0.38
N;N
PhyloP100
3.1
PrimateAI
Benign
0.42
T
PROVEAN
Benign
0.020
N;N
REVEL
Benign
0.28
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.12
B;B
Vest4
0.21
MutPred
0.69
Gain of disorder (P = 0.158);Gain of disorder (P = 0.158);
MVP
0.74
MPC
0.026
ClinPred
0.11
T
GERP RS
5.8
Varity_R
0.22
gMVP
0.63
Mutation Taster
=74/26
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs565977953; hg19: chr8-71573999; API